Corvus Pharmaceuticals CRVS
Last Price
52 Week Range
$2.54 - $26.95
Next Earnings Date
Mar 24 2026 (Estimate)
Next Earnings Date
Mar 24 2026 (Est.)
Last Price
CRVS Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Corvus Pharmaceuticals, Inc. | 8-K | January 23, 2026 | |
Corvus Pharmaceuticals, Inc. | 8-K | January 20, 2026 | |
Corvus Pharmaceuticals, Inc. | 8-K | January 20, 2026 | |
Corvus Pharmaceuticals, Inc. | 10-Q | November 4, 2025 | |
Corvus Pharmaceuticals, Inc. | 8-K | November 4, 2025 | |
Corvus Pharmaceuticals, Inc. | 8-K | October 2, 2025 | |
Corvus Pharmaceuticals, Inc. | 10-Q | August 7, 2025 | |
Corvus Pharmaceuticals, Inc. | 8-K | August 7, 2025 | |
Corvus Pharmaceuticals, Inc. | 8-K | June 13, 2025 | |
Corvus Pharmaceuticals, Inc. | 8-K | June 4, 2025 | |
Corvus Pharmaceuticals, Inc. | 8-K | May 8, 2025 | |
Corvus Pharmaceuticals, Inc. | 10-Q | May 8, 2025 | |
Corvus Pharmaceuticals, Inc. | DEFA14A | April 25, 2025 | |
Corvus Pharmaceuticals, Inc. | DEF 14A | April 25, 2025 | |
Corvus Pharmaceuticals, Inc. | 8-K | April 9, 2025 | |
Corvus Pharmaceuticals, Inc. | 8-K | March 25, 2025 | |
Corvus Pharmaceuticals, Inc. | 10-K | March 25, 2025 | |
Corvus Pharmaceuticals, Inc. | 8-K | January 13, 2025 | |
Corvus Pharmaceuticals, Inc. | 8-K | December 18, 2024 | |
Corvus Pharmaceuticals, Inc. | 10-Q | November 12, 2024 | |
Corvus Pharmaceuticals, Inc. | 8-K | November 12, 2024 | |
Corvus Pharmaceuticals, Inc. | 8-K | October 23, 2024 | |
Corvus Pharmaceuticals, Inc. | 8-K | August 6, 2024 | |
Corvus Pharmaceuticals, Inc. | 10-Q | August 6, 2024 | |
Corvus Pharmaceuticals, Inc. | 8-K | June 14, 2024 | |
Corvus Pharmaceuticals, Inc. | 10-Q | May 7, 2024 | |
Corvus Pharmaceuticals, Inc. | 8-K | May 6, 2024 | |
Corvus Pharmaceuticals, Inc. | 8-K | May 6, 2024 | |
Corvus Pharmaceuticals, Inc. | 8-K | May 1, 2024 | |
Corvus Pharmaceuticals, Inc. | DEF 14A | April 26, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.